FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/04/051838 [Registered on: 21/04/2023] Trial Registered Prospectively
Last Modified On: 20/04/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Other 
Public Title of Study   Evaluate the effect of Madhukadi Lauha in Timir w.s.r. to Myopia 
Scientific Title of Study   A Clinical study to Evaluate the effect of Madhukadi Lauha in Timir w.s.r. to Myopia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sukhdev Singh 
Designation  Sr. Lecturer, M.S. (Ayu.) Shalakya Tantra  
Affiliation  Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital, Paprola Distt. Kangra, H.P. 
Address  Room No. 210,Anatomy block RGGPG Ayurvedic College and Hospital Paprola, Kangra. (H.P.)
OPD 219 RGGPG Ayurvedic College and Hospital Paprola, Kangra. (H.P.)
Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418471230  
Fax    
Email  drsukhdev@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sukhdev Singh 
Designation  Sr. Lecturer, M.S. (Ayu.) Shalakya Tantra  
Affiliation  Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital, Paprola Distt. Kangra, H.P. 
Address  Room No. 210,Anatomy block RGGPG Ayurvedic College and Hospital Paprola, Kangra. (H.P.)
OPD 219 RGGPG Ayurvedic College and Hospital Paprola, Kangra. (H.P.)
Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418471230  
Fax    
Email  drsukhdev@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tanisha Pathania 
Designation  PG Scholar 
Affiliation  R. G. G. P. G. Ayurvedic College & Hospital Paprola, Kangra. (H.P.) 
Address  RGGPG Ayurvedic College and Hospital Paprola, Kangra. (H.P.)
OPD 219 RGGPG Ayurvedic College and Hospital Paprola, Kangra. (H.P.)
Kangra
HIMACHAL PRADESH
176115
India 
Phone  8628868287  
Fax    
Email  tanishapathania41@gmail.com  
 
Source of Monetary or Material Support  
Baijnath Pharmacy, Paprola, Distt. Kangra, H.P. Charak Pharmacy, RGGPG Ayurvedic College, Paprola, Kangra Research institute in I.S.S.M. Jogindernagar, H.P. 
 
Primary Sponsor  
Name  Principal, RGGPG Ayurvedic College& Hospiyal Paprola, Kangra 
Address  RGGPG Ayurvedic College & Hospital Paprola, Kangra 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr Sukhdev Singh  RGGPG Ayurvedic College & Hospital, Paprola, Kangra 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sukhdev Singh  RGGPG Ayurvedic College and Hospital, Paprola, Kangra.  OPD 219 RGGPG Ayurvedic College and Hospital, Paprola, Kangra
Kangra
HIMACHAL PRADESH 
9418471230

drsukhdev@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee RGGPG Ayurvedic College and Hospital, Paprola, Kangra.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H521||Myopia. Ayurveda Condition: TIMIRAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Madhukadi Lauha, Reference: Bhaishjya Ratnavali, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: water), Additional Information: follow up after 15 days till completion of trial.
2Intervention ArmDrugClassical(1) Medicine Name: Madhukadi Lauha, Reference: Bhaishjya Ratnavali, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Ghrita 2g and Madhu 1g), Additional Information: follow up after 15 days till completion of trial. Delete
 
Inclusion Criteria  
Age From  8.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  Patients willing for trial.
b. Patients having Myopia with normal ophthalmoscopic findings. 
 
ExclusionCriteria 
Details  a. Patients not willing for trial.
b. Patients below 8 years and above 30 years of age.
c. Patients having lenticular changes and ocular diseases like - Glaucoma,
Cataract, Corneal Opacity, Corneal Ulcer, Age related macular degeneration,
Uveitis, Stye, Triachiasis, Diabetic Retinopathy, Strabismus etc.
d. Associated symptoms i.e. fever, malaise and lymphadenopathy.
e. Patients having systemic disorders i.e. Cardio vascular disorder, Diabetes and
hypertension. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
improved distant vision on Snellens chart.  4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
feeling of well being  30 days 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   21/04/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Twenty patients fulfilling the inclusion criteria will be selected and divided into two groups. 
Both the groups of patients  will be treated with  Madhukadi Lauha with different anupan. The outcome will be analysed with appropriate statistical tools.
 
Close